IL299997A - Methods and preparations for the treatment of lung conditions - Google Patents
Methods and preparations for the treatment of lung conditionsInfo
- Publication number
- IL299997A IL299997A IL299997A IL29999723A IL299997A IL 299997 A IL299997 A IL 299997A IL 299997 A IL299997 A IL 299997A IL 29999723 A IL29999723 A IL 29999723A IL 299997 A IL299997 A IL 299997A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical composition
- ntfs
- msc
- exo
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063053780P | 2020-07-20 | 2020-07-20 | |
| US202163133350P | 2021-01-03 | 2021-01-03 | |
| PCT/IL2021/050885 WO2022018729A1 (en) | 2020-07-20 | 2021-07-20 | Methods and compositions for treating lung conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL299997A true IL299997A (en) | 2023-03-01 |
Family
ID=77265158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL299997A IL299997A (en) | 2020-07-20 | 2021-07-20 | Methods and preparations for the treatment of lung conditions |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230310507A1 (https=) |
| EP (1) | EP4181935A1 (https=) |
| JP (2) | JP7691488B2 (https=) |
| AU (1) | AU2021313472B2 (https=) |
| CA (1) | CA3189818A1 (https=) |
| IL (1) | IL299997A (https=) |
| WO (1) | WO2022018729A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3801028A4 (en) | 2018-05-30 | 2022-04-13 | Direct Biologics LLC | A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use |
| US12569517B2 (en) | 2019-02-07 | 2026-03-10 | Direct Biologics, Llc | Method for treating osteoarthritis with mesenchymal stem cell exosomes |
| US12213995B2 (en) | 2019-07-18 | 2025-02-04 | Direct Biologics, Llc | Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use |
| CN113384597A (zh) * | 2020-03-13 | 2021-09-14 | 西比曼生物科技（上海）有限公司 | 含人体细胞衍生的细胞膜外囊泡的雾化吸入制剂、制法及其应用 |
| KR20230004709A (ko) | 2020-04-22 | 2023-01-06 | 다이렉트 바이오로직스 엘엘씨 | 감염성 질환과 연관된 염증성 병태를 치료하기 위한 방법 및 조성물 |
| WO2022114730A2 (ko) * | 2020-11-26 | 2022-06-02 | 사회복지법인 삼성생명공익재단 | 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 감염성 질환 치료용 조성물 |
| KR20240003167A (ko) * | 2022-06-30 | 2024-01-08 | 주식회사 지씨셀 | 편도유래줄기세포를 유효성분으로 포함하는 감염성 폐 질환의 예방 또는 치료용 조성물 |
| WO2024236603A1 (en) * | 2023-05-18 | 2024-11-21 | Khorakiwala Zahabiya | Growth factor concentrate composition |
| CN116897887A (zh) * | 2023-07-31 | 2023-10-20 | 湖南中医药大学 | 一种病毒性哮喘动物模型的构建方法 |
| US12502407B2 (en) | 2024-04-25 | 2025-12-23 | Direct Biologics, Llc | Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080095749A1 (en) | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
| US9901600B2 (en) | 2011-03-11 | 2018-02-27 | Children's Medical Center Corporation | Methods and compositions relating to mesenchymal stem cell exosomes |
| DK2880151T3 (da) * | 2012-08-06 | 2020-08-17 | Brainstorm Cell Therapeutics Ltd | Fremgangsmåder til frembringelse af mesenkymale stemceller, som udskiller neurotrofiske faktorer |
| WO2015016761A2 (en) * | 2013-08-01 | 2015-02-05 | Isletone Ab | Mscs in the treatment of inflammatory pulmonary diseases |
| KR101843634B1 (ko) | 2016-04-15 | 2018-03-30 | 사회복지법인 삼성생명공익재단 | 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 만성폐질환 치료용 조성물 |
| CN111212653A (zh) * | 2017-08-15 | 2020-05-29 | 儿童医学中心公司 | 经纯化间充质干细胞外排体及其用途 |
| GB2568255A (en) * | 2017-11-08 | 2019-05-15 | Evox Therapeutics Ltd | Exosomes comprising RNA therapeutics |
| US12233092B2 (en) | 2018-04-10 | 2025-02-25 | Brainstorm Cell Therapeutics Ltd. | MSC-NTF specific exosomes and use thereof |
| EP4344739A3 (en) * | 2018-06-29 | 2024-05-29 | North Carolina State University | Therapeutic lung repair by inhalation of lung spheroid cell-secreted factors |
| CA3170255A1 (en) * | 2020-03-05 | 2021-09-10 | Silviu Itescu | Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells |
| US20230105667A1 (en) * | 2020-03-12 | 2023-04-06 | Exostem Biotec Ltd. | Mesenchymal stromal cells and extracellular vesicles for treating viral infections, inflammation, and tissue fibrosis |
| BR112022020042A2 (pt) * | 2020-04-03 | 2022-11-22 | Mesoblast Int Sarl | Método para tratar hiperinflamação com o uso de células-tronco ou precursoras de linhagem mesenquimal |
| EP4132479A1 (en) * | 2020-04-07 | 2023-02-15 | Ramot at Tel-Aviv University Ltd. | Cannabidiol-containing compositions and uses thereof |
-
2021
- 2021-07-20 EP EP21752252.3A patent/EP4181935A1/en active Pending
- 2021-07-20 JP JP2023503444A patent/JP7691488B2/ja active Active
- 2021-07-20 CA CA3189818A patent/CA3189818A1/en active Pending
- 2021-07-20 AU AU2021313472A patent/AU2021313472B2/en active Active
- 2021-07-20 US US18/016,460 patent/US20230310507A1/en active Pending
- 2021-07-20 WO PCT/IL2021/050885 patent/WO2022018729A1/en not_active Ceased
- 2021-07-20 IL IL299997A patent/IL299997A/en unknown
-
2025
- 2025-05-29 JP JP2025089972A patent/JP2025128209A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4181935A1 (en) | 2023-05-24 |
| AU2021313472B2 (en) | 2025-10-16 |
| JP7691488B2 (ja) | 2025-06-11 |
| AU2021313472A1 (en) | 2023-02-23 |
| CA3189818A1 (en) | 2022-01-27 |
| JP2023534524A (ja) | 2023-08-09 |
| US20230310507A1 (en) | 2023-10-05 |
| WO2022018729A1 (en) | 2022-01-27 |
| JP2025128209A (ja) | 2025-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL299997A (en) | Methods and preparations for the treatment of lung conditions | |
| Fröhlich et al. | Oral inhalation for delivery of proteins and peptides to the lungs | |
| ES2373238T3 (es) | Estabilizadores para vacunas liofilizadas. | |
| Carvalho et al. | Hyperoxia and lung disease | |
| US20230110614A1 (en) | Heparin and n-acetylcysteine for the treatment of a respiratory virus | |
| RU2010139478A (ru) | Соединенные с сахарным стеклом вирусоподобные частицы (vlp) | |
| Wanner et al. | Clinical indications for and effects of bland, mucolytic, and antimicrobial aerosols | |
| JP6041361B2 (ja) | 生物学的製品、特にはワクチンの真空保存 | |
| JP2011522553A5 (https=) | ||
| CA2428073A1 (en) | Paramyxovirus vector for gene transfer to the cardiovascular system | |
| FI3710036T3 (fi) | Stabiileja askorbiinihappokoostumuksia ja menetelmiä niiden käyttämiseksi | |
| JP2023520323A5 (https=) | ||
| JP2023126658A5 (https=) | ||
| JP2023520233A5 (https=) | ||
| JP2023509462A5 (https=) | ||
| JP2007511539A5 (https=) | ||
| RU2012156256A (ru) | Факторы трилистника (tff) для лечения хронических заболеваний легких | |
| JP2023539940A5 (https=) | ||
| JP2023518269A5 (https=) | ||
| De Luca et al. | Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review | |
| JP2021521280A5 (https=) | ||
| WO2015132392A1 (en) | Compositions for treating lung infections by airway administration | |
| Chenaud et al. | Bacterial croup and toxic shock syndrome | |
| Van Daal et al. | Acute respiratory failure during pneumonia induced by Sendai virus | |
| JP2023524150A5 (https=) |